In the case of rare or chronic illnesses in particular, promising new therapies may be used outside the indication, or a new drug may not yet be available or not be approved in Switzerland. A commitment to cover costs is required if a medication is to be used outside the approved indication, otherwise reimbursement is not guaranteed. The same applies if a drug has not yet been approved. In such cases, MediService clarifies reimbursement issues with the responsible authorities (health insurance, prescribers and, if necessary, pharmaceutical companies) in advance and then enables the purchase of the medication. This provides access to new therapies for patients who would otherwise have no further alternative.
If a patient requires a novel therapy that is only available abroad, we take care of the necessary formalities and import the medication for this patient. This enables us to provide access to drugs for which there are no alternatives available on the Swiss market yet. In addition, we ensure uncomplicated settlement of costs through the health insurance company by means of an advance commitment to cover costs. Delivery can be conveniently made to any address in Switzerland.
Doctors should be able to devote as much of their time as possible to their patients and not be burdened with administrative work. For certain types of medication that require a commitment to cover costs from the health insurance company, we help doctors complete an application for a commitment to cover costs and then submit it to the health insurance company. We regularly check the processing status of the application with the health insurance company.
In the case of time-limited commitments to cover costs, we also monitor the deadlines and send a reminder to the doctor before the commitment to cover costs expires. This allows the subsequent application to be submitted early enough to ensure seamless treatment.
